MARKET

CELG-RT

CELG-RT

Bristol-Myers Squibb Company Celegne Contingent Value Rights
NYSE
0.0332
-0.0012
-3.49%
Closed 15:27 07/17 EDT
OPEN
0.0281
PREV CLOSE
0.0344
HIGH
0.0332
LOW
0.0281
VOLUME
3.00K
TURNOVER
17
52 WEEK HIGH
0.1550
52 WEEK LOW
0.0150
MARKET CAP
--
P/E (TTM)
0.0125
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CELG RT last week (0630-0704)?
Weekly Report · 07/07 09:13
Weekly Report: what happened at CELG RT last week (0623-0627)?
Weekly Report · 06/30 09:13
Weekly Report: what happened at CELG RT last week (0616-0620)?
Weekly Report · 06/23 09:13
Weekly Report: what happened at CELG RT last week (0609-0613)?
Weekly Report · 06/16 09:13
Weekly Report: what happened at CELG RT last week (0602-0606)?
Weekly Report · 06/09 09:13
Weekly Report: what happened at CELG RT last week (0526-0530)?
Weekly Report · 06/02 09:14
Weekly Report: what happened at CELG RT last week (0519-0523)?
Weekly Report · 05/26 09:14
Weekly Report: what happened at CELG RT last week (0512-0516)?
Weekly Report · 05/19 09:13
More
About CELG-RT
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its platforms comprise chemically synthesized or small molecule drugs, including protein degraders; drugs produced from biological processes, called biologics; ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are also used. Biologics are typically administered through injections or by intravenous infusion. CAR-T cell therapies are administered by intravenous infusion. Its growth portfolio includes Opdivo, Opdivo Qvantig, Orencia, Yervoy, Reblozyl, Opdualag, and others. Its legacy portfolio includes Eliquis, Revlimid, Pomalyst/Imnovid, Sprycel and Abraxane.

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: CELG RT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELG RT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELG-RT stock methods without spending real money on the virtual paper trading platform.